Inventor · disambiguated record
Cecilia Deantonio
Also filed as: DEANTONIO CECILIA
3 granted patents·9 pending applications·31 citations·filing 2017–2024
69Inventor score
Top patents by PatentIndex Score
12 records- 0196US9957323B2Anti-ICOS antibodiesKYMAB LTD·Filed 2017·Granted May 1, 2018·27 cites·26 claims
- 0288US12209128B2Anti-PD-L1 antibodiesKYMAB LTD·Filed 2021·Granted Jan 28, 2025·1 cites·6 claims
- 0388US11965026B2Anti-PD-L1 and IL-2 cytokinesKYMAB LTD·Filed 2017·Granted Apr 23, 2024·3 cites·19 claims
- 0483US2024360218A1Anti-pd-l1 and il-2 cytokinesKYMAB LTD·Filed 2024·Application pending·0 cites
- 0583US2024343810A1Multispecific antibodies for immuno-oncologyKYMAB LTD·Filed 2024·Application pending·0 cites
- 0677US2022380467A1Anti-icos antibodiesKYMAB LTD·Filed 2022·Application pending·0 cites
- 0777US2022403029A1Anti-icos antibodiesKYMAB LTD·Filed 2022·Application pending·0 cites
- 0877US2023312720A1Multispecific antibodies for immuno-oncologyKYMAB LTD·Filed 2022·Application pending·0 cites
- 0963US2024190964A1Treatment of pd-l1 negative or low expressing cancer with anti-icos antibodiesKYMAB LTD·Filed 2023·Application pending·0 cites
- 1061US2025019441A1Treatment of cancer with anti-ilt2 antibodiesBIOND BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1156US2020190191A1Multispecific antibody with combination therapy for immuno-oncologyKYMAB LTD·Filed 2017·Application pending·0 cites
- 1250US2023176060A1Tumour biomarkers for immunotherapyKYMAB LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cecilia Deantonio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →